Edges in Network
Network | GSE25065_egf1520 - GSE25065 - SiGN-BN HC+Bootstrap |
Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
Node | ATF2 |
Upstream (Parents) |
---|
(<<) CDH11 → ATF2 |
(<<) CHPF → ATF2 |
(<<) CREB1 → ATF2 |
(<<) CRTC1 → ATF2 |
(<<) E2F3 → ATF2 |
(<<) EIF4E → ATF2 |
(<<) GNG10 → ATF2 |
(<<) JAK2 → ATF2 |
(<<) PALM → ATF2 |
(<<) PLA2G12A → ATF2 |
(<<) RASA1 → ATF2 |
(<<) SEH1L → ATF2 |
(<<) SMO → ATF2 |
(<<) SP3 → ATF2 |
Downstream (Children) |
---|
ATF2 → ATP2C1 (>>) |
ATF2 → B3GNT2 (>>) |
ATF2 → CASP8 (>>) |
ATF2 → CEBPD (>>) |
ATF2 → CEBPE (>>) |
ATF2 → CHST10 (>>) |
ATF2 → CISH (>>) |
ATF2 → CYP1A1 (>>) |
ATF2 → DDX18 (>>) |
ATF2 → DNAJA1 (>>) |
ATF2 → EP300 (>>) |
ATF2 → ETS1 (>>) |
ATF2 → EZR (>>) |
ATF2 → FUT2 (>>) |
ATF2 → GNAL (>>) |
ATF2 → GNRH2 (>>) |
ATF2 → GRIN1 (>>) |
ATF2 → GYS1 (>>) |
ATF2 → HCN2 (>>) |
ATF2 → HK1 (>>) |
ATF2 → HS2ST1 (>>) |
ATF2 → HSPA9 (>>) |
ATF2 → IMPA1 (>>) |
ATF2 → INF2 (>>) |
ATF2 → INPPL1 (>>) |
ATF2 → ITGB6 (>>) |
ATF2 → LYPLA2 (>>) |
ATF2 → MAFF (>>) |
ATF2 → MAP3K11 (>>) |
ATF2 → MAP3K3 (>>) |
ATF2 → MEX3D (>>) |
ATF2 → MT1G (>>) |
ATF2 → MTRR (>>) |
ATF2 → NCOA3 (>>) |
ATF2 → NCOR2 (>>) |
ATF2 → NEUROG1 (>>) |
ATF2 → NFKB1 (>>) |
ATF2 → NOC3L (>>) |
ATF2 → NRSN2 (>>) |
ATF2 → PIK3R5 (>>) |
ATF2 → PKM2 (>>) |
ATF2 → PNO1 (>>) |
ATF2 → PNPLA3 (>>) |
ATF2 → PPP1R11 (>>) |
ATF2 → PPP3CC (>>) |
ATF2 → PRKAA1 (>>) |
ATF2 → PRKCG (>>) |
ATF2 → PRKCI (>>) |
ATF2 → PTMA (>>) |
ATF2 → RAC1 (>>) |
ATF2 → RBM7 (>>) |
ATF2 → RCBTB1 (>>) |
ATF2 → RNF138 (>>) |
ATF2 → RPS12 (>>) |
ATF2 → RPS6KB2 (>>) |
ATF2 → RXRB (>>) |
ATF2 → SERPINB1 (>>) |
ATF2 → SHC2 (>>) |
ATF2 → SLMO2 (>>) |
ATF2 → SMURF2 (>>) |
ATF2 → STAM2 (>>) |
ATF2 → TAF1A (>>) |
ATF2 → THBS1 (>>) |
ATF2 → TRAF6 (>>) |
ATF2 → TUBA1A (>>) |
ATF2 → VEGFB (>>) |
ATF2 → YWHAZ (>>) |
ATF2 → ZNF215 (>>) |